Dr Gareth Blades - AnalystDr Gareth Blades joined Amati in 2019 as an Analyst supporting the fund management team. Prior to Amati, Gareth worked as an independent consultant supporting early stage life science companies in their operational and strategic decision making. In 2016 he worked for the College of Medicine and Veterinary Medicine at the University of Edinburgh building and spinning-out therapeutic, med-tech, diagnostic and e-health companies. In 2015, Gareth worked in healthcare corporate finance at PharmaVentures in Oxford. During his time at PharmaVentures he delivered expert reports, business development, licensing and due diligence projects for international clients. Prior to this he worked for White Space Strategy in Oxford, a leading market analysis and strategy consultancy serving financial services, TMT, manufacturing, energy and public sector clients. Gareth has a DPhil in Systems Biology - Biochemistry from the University of Oxford, an MPhil in Micro and Nanotechnology Enterprise from the University of Cambridge and a first in Neuroscience from Cardiff University.
Amati Newsletter (Issue 16)
Posted by Newsletter on 21/Dec/2020
Topics covered within this issue:
- Awards: Winner of Specialist VCT & Boutique of the Year Award 2020
- Amati AIM VCT Fundraising
- Amati's Approach to ESG Investing
- Portfolio Company Spotlight: HeiQ, Eqtec & Renalytix AI
- Charity Update: Children 1st & Feedback Madagascar
- Amati Quiz: Chance to win Limited Bottle of Whisky
- Amati People
Amati Newsletter Issue 16
Feedback Madagascar Video Clips.
Should you wish to subscribe to receive our newsletter by email, please contact: email@example.com or call 0131 503 9115